Childhood asthma, inhaled corticosteroid exposure, and risk of cataract in adulthood: a register-based study
International Ophthalmology · 2025
DOI: 10.1007/s10792-025-03586-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von Osman Savran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark. osmansavran@outlook.dk. Hauptthemen laut MEDLINE: Cataract, Asthma, Registries, Glucocorticoids. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beckett-Fonden, Hvidovre Hospital, Skibsreder Per Henriksen, R. og hustrus fond.
Abstract (Originalsprache)
Background
Cataract is the leading cause of blindness worldwide, with corticosteroid treatment being a known risk factor. The long-term impact of childhood asthma and, particularly, inhaled corticosteroid (ICS) use in adulthood on cataract development remains unclear.
Methods
This register-based study investigated the prevalence and risk of cataract in Danish adults diagnosed with childhood asthma who, between 1950 and 1979, spent four months at an asthma care facility in Kongsberg, Norway. Follow-up was conducted in 2021 using Danish national health registries (2006–2018). These individuals were compared to an age- and sex-matched control group with no history of obstructive airway disease. Participants were stratified by ICS treatment duration and daily dose. Conditional logistic regression was used to assess associations.
Results
The study included 1394 adults with childhood asthma and 1394 controls (mean age 63 years; 43% female). Cataract prevalence was 6.1% in the childhood asthma cohort versus 4.3% in controls ( p = 0.03). Compared to controls, individuals with childhood asthma had increased odds of cataract (OR 1.47, 95% CI 1.04–2.08, p = 0.03). Among those treated with ICS, the odds were higher (OR 1.75, 95% CI 1.19–2.57, p < 0.01), with the risk increasing in proportion to ICS dose and treatment duration. No significant difference in cataract risk was found between individuals with childhood asthma who did not receive ICS and controls (OR 1.12, 95% CI 0.69–1.79, p = 0.65).
Conclusions
Childhood asthma diagnosis alone was not associated with increased cataract risk. However, among those treated with ICS in adulthood, there was a significantly elevated risk, which increased with higher doses and longer treatment durations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark. osmansavran@outlook.dk.
- Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark. osmansavran@outlook.dk.
- Department of Ophthalmology, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.
- Department of Clinical Medicine, University of Copenhagen, København, Denmark.
- Øjenklinikken Diakonissestiftelsen, Frederiksberg, Denmark.
- Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark.
Förderung
- Beckett-Fonden
- Hvidovre Hospital
- Skibsreder Per Henriksen, R. og hustrus fond
- National Hospital
Zitieren
APA
Savran, O., Bach-Holm, D., Nørregaard, J. C., Kessel, L., & Ulrik, C. S. (2025). Childhood asthma, inhaled corticosteroid exposure, and risk of cataract in adulthood: a register-based study. International Ophthalmology. https://doi.org/10.1007/s10792-025-03586-3
Vancouver
Savran O, Bach-Holm D, Nørregaard JC, Kessel L, Ulrik CS. Childhood asthma, inhaled corticosteroid exposure, and risk of cataract in adulthood: a register-based study. International Ophthalmology. 2025. doi:10.1007/s10792-025-03586-3
BibTeX
@article{Savran2025,
author = {Savran, Osman and Bach-Holm, Daniella and Nørregaard, Jens Christian and Kessel, Line and Ulrik, Charlotte Suppli},
title = {Childhood asthma, inhaled corticosteroid exposure, and risk of cataract in adulthood: a register-based study},
journal = {International Ophthalmology},
year = {2025},
doi = {10.1007/s10792-025-03586-3}
}
EUVIMED